{"created":"2023-06-23T12:18:28.989557+00:00","id":9122,"links":{},"metadata":{"_buckets":{"deposit":"98f05522-87c5-4b47-bd8d-c5674d3f9dbb"},"_deposit":{"created_by":21,"id":"9122","owners":[21],"pid":{"revision_id":0,"type":"depid","value":"9122"},"status":"published"},"_oai":{"id":"oai:asahi-u.repo.nii.ac.jp:00009122","sets":["49:132:366"]},"author_link":["12611","12615","12613","12614","12616","12612"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-11-29","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"Asia-Pacific journal of clinical oncology","bibliographic_titleLang":"en"}]}]},"item_10001_description_19":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Visualization of fiducial gold markers is critical for registration on computed tomography (CT) and magnetic resonance imaging (MRI) for imaging-guided radiotherapy. Although larger markers provide better visualization on MRI, they tend to generate artifacts on CT. MRI is strongly influenced by the presence of metals, such as iron, in the body. Here we compared efficacies of a 0.5% iron-containing gold marker (GM) and a traditional non-iron-containing marker.","subitem_description_type":"Abstract"},{"subitem_description":"Twenty-seven patients underwent CT/MRI fusion-based intensity-modulated radiotherapy. Markers were placed by urologists under local anesthesia. Gold Anchor (GA; diameter: 0.28 mm; length: 10 mm), an iron-containing marker, was placed on the right side of the prostate using a 22-G needle and VISICOIL (VIS; diameter: 0.35 mm; length: 10 mm), a non-iron-containing marker, was placed on the left side using a 19-G needle. T2*-weighted images MRI sequences were obtained. Two radiation oncologists and a radiation technologist evaluated and assigned scores for visual quality on a five-point scale (1, poor; 5, best visibility).","subitem_description_type":"Abstract"},{"subitem_description":"Artifact generation on CT was slightly greater with GA than with VIS. The mean marker visualization scores on MRI of all three observers were significantly superior for GA than for VIS (3.5 vs 3.2, 3.9 vs 3.2, and 4.0 vs 2.9). The actual size of the spherical GA was about 2 mm in diameter, but the signal void on MRI was approximately 5 mm.","subitem_description_type":"Abstract"},{"subitem_description":"Although both markers were well visualized and can be recommended clinically, the results suggest that GA has some subtle advantages for quantitative visualization that could prove useful in certain situations of stereotactic body radiotherapy and intensity-modulated radiotherapy.","subitem_description_type":"Abstract"}]},"item_10001_description_6":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"Visualization of fiducial gold markers is critical for registration on computed tomography (CT) and magnetic resonance imaging (MRI) for imaging-guided radiotherapy. Although larger markers provide better visualization on MRI, they tend to generate artifacts on CT. MRI is strongly influenced by the presence of metals, such as iron, in the body. Here we compared efficacies of a 0.5% iron-containing gold marker (GM) and a traditional non-iron-containing marker.","subitem_description_type":"Other"},{"subitem_description":"Twenty-seven patients underwent CT/MRI fusion-based intensity-modulated radiotherapy. Markers were placed by urologists under local anesthesia. Gold Anchor (GA; diameter: 0.28 mm; length: 10 mm), an iron-containing marker, was placed on the right side of the prostate using a 22-G needle and VISICOIL (VIS; diameter: 0.35 mm; length: 10 mm), a non-iron-containing marker, was placed on the left side using a 19-G needle. T2*-weighted images MRI sequences were obtained. Two radiation oncologists and a radiation technologist evaluated and assigned scores for visual quality on a five-point scale (1, poor; 5, best visibility).","subitem_description_type":"Other"},{"subitem_description":"Artifact generation on CT was slightly greater with GA than with VIS. The mean marker visualization scores on MRI of all three observers were significantly superior for GA than for VIS (3.5 vs 3.2, 3.9 vs 3.2, and 4.0 vs 2.9). The actual size of the spherical GA was about 2 mm in diameter, but the signal void on MRI was approximately 5 mm.","subitem_description_type":"Other"},{"subitem_description":"Although both markers were well visualized and can be recommended clinically, the results suggest that GA has some subtle advantages for quantitative visualization that could prove useful in certain situations of stereotactic body radiotherapy and intensity-modulated radiotherapy.","subitem_description_type":"Other"}]},"item_10001_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"29193796","subitem_relation_type_select":"PMID"}}]},"item_10001_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"info:doi/10.1111/ajco.12830","subitem_relation_type_select":"DOI"}}]},"item_10001_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"出版社版(SpringerLink)"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1007/s12029-017-0026-7","subitem_relation_type_select":"DOI"}}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1743-7563","subitem_source_identifier_type":"ISSN"}]},"item_10001_textarea_24":{"attribute_name":"所属","attribute_value_mlt":[{"subitem_textarea_value":"Department of RadiationOncology, Murakami Memorial Hospital, 3–23 Hashimoto-cho, Gifu City,Gifu, Japan"},{"subitem_textarea_value":"Department of Urology, Gifu Municipal Hospital, Gifu City,Gifu, Japan"},{"subitem_textarea_value":"Division of Radiation Service, Gifu Municipal Hospital, Gifu City,Gifu, Japan"},{"subitem_textarea_value":"Department of RadiationOncology, Murakami Memorial Hospital, 3–23 Hashimoto-cho, Gifu City,Gifu, Japan"},{"subitem_textarea_value":"Department of RadiationOncology, Murakami Memorial Hospital, 3–23 Hashimoto-cho, Gifu City,Gifu, Japan"},{"subitem_textarea_value":"Department of Radiology, Gifu University School of Medicine,Gifu City, Gifu, Japan"}]},"item_10001_textarea_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_textarea_value":"Wiley"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Tanaka, Osamu"}],"nameIdentifiers":[{"nameIdentifier":"12611","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Komeda, Hisao"}],"nameIdentifiers":[{"nameIdentifier":"12612","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hirose, Shigeki"}],"nameIdentifiers":[{"nameIdentifier":"12613","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Taniguchi, Takuya"}],"nameIdentifiers":[{"nameIdentifier":"12614","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ono, Kousei"}],"nameIdentifiers":[{"nameIdentifier":"12615","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Matsuo, Masayuki"}],"nameIdentifiers":[{"nameIdentifier":"12616","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-11-30"}],"displaytype":"detail","filename":"17437563_Nov29_17_2017.pdf","filesize":[{"value":"900.3 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"17437563_Nov29_17_2017","url":"https://asahi-u.repo.nii.ac.jp/record/9122/files/17437563_Nov29_17_2017.pdf"},"version_id":"0f79b146-71ca-43ad-8ec6-2a183d4cdee5"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"fiducial marker","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"MRI","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"prostate radiotherapy","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy."},{"subitem_title":"Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"21","path":["366"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-11-29"},"publish_date":"2018-11-29","publish_status":"0","recid":"9122","relation_version_is_last":true,"title":["Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy."],"weko_creator_id":"21","weko_shared_id":-1},"updated":"2023-06-23T13:48:59.350778+00:00"}